Lipella Pharmaceuticals Inc.
LIPO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,855,771 | $2,782 | $4,225 | $2,185 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $42 | $86 | $85 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $223,517 | $0 | -$0 | $0 |
| Total Curr. Assets | $2,079,288 | $3,437 | $4,823 | $2,617 |
| Property Plant & Equip (Net) | $262,823 | $283 | $33 | $57 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7,699 | $0 | $0 | $0 |
| Total NC Assets | $270,522 | $283 | $33 | $57 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,349,810 | $3,720 | $4,856 | $2,674 |
| Liabilities | – | – | – | – |
| Payables | $462,892 | $608 | $392 | $388 |
| Short-Term Debt | $44,267 | $42,903 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $135,240 | -$42,903 | -$0 | $0 |
| Total Curr. Liab. | $642,399 | $747 | $777 | $754 |
| LT Debt | $219,816 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $219,816 | $232 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $264,083 | $275 | $24 | $48 |
| Total Liabilities | $862,215 | $979 | $777 | $754 |
| Equity | – | – | – | – |
| Pref Stock | $1 | $0 | $0 | $0 |
| Common Stock | $462 | $0 | $0 | $0 |
| Retained Earnings | -$19,228,194 | -$17,974 | -$16,647 | -$15,340 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $20,715,327 | $0 | $0 | $0 |
| Total Equity | $1,487,595 | $2,742 | $4,079 | $1,919 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,349,810 | $3,720 | $4,856 | $2,674 |
| Net Debt | -$1,591,688 | $40,121 | -$4,225 | -$2,185 |